PDF
ePub
Citation
Print
Abstract
Purpose
Proper preoperative staging is important in planning optimal therapy for individual patients and improving outcome. There is no ideal imaging methods for accurate colorectal cancer staging. The purpose of our study was to determine the usefulness of fluorodeoxyglucose positron emission tomography (FDG-PET)/computed tomography (CT) for the status of regional lymph node metastasis in colorectal cancer.
Methods
Two hundred forty six surgically resected colorectal cancers were retrospectively reviewed from Jan 2007 to Jul 2009. All patients underwent abdominal CT and FDG-PET/CT preoperatively.
Results
There were 129 males (52.4%) and the mean age was 62 (range: 25~88 years). Tumor location was the colon in 148 (59.7%) patients, and the rectum in 98 (40.3%) patients. Pathological stages were I: 43 (17.5%), II: 78 (31.7%), III: 81 (32.9%), IV: 44 (17.9%). Regional lymph node metastasis by pathological examination was 118 (48%) patients. The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of regional lymph node staging were 66.4%, 66.7%, 64.8%, 68.3%, and 67%, respectively, with the FDG-PET/CT, and 57.1%, 71.3%, 64.8%, 64.3%, and 65%, respectively, with whole abdominal CT. The difference in the accuracy of nodal staging between the two modalities was not significant.
Conclusion
The diagnostic accuracy of FDG-PET/CT for the assessment of regional lymph node metastasis in colorectal cancer was relatively low, and similar to that of abdominal CT. Therefore, further study will be needed to determine the clinical usefulness of preoperative FDG-PET/CT in colorectal cancer.
Figures and Tables
Fig. 1
(A) Computed tomography (CT) transaxial image. Preoperative CT shows irregular wall thickness and pericolic fat infiltration of ascending colon and pericolic lymph node (LN) enlargement. (B) 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) fused transaxial image. Preoperative FDG-PET/CT shows FDG uptake of ascending colon, pericolic and ileocolic LN.
References
1. Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst. 2007. 99:433–441.
2. Smith AJ, Driman DK, Spithoff K, Hunter A, McLeod RS, Simunovic M, et al. Guideline for optimization of colorectal cancer surgery and pathology. J Surg Oncol. 2010. 101:5–12.
3. Faggi U, Giovane A, Cardini S, Falchi S. Short-term results in colorectal surgery. Statistical analysis about mortality, morbidity and hospital stay. Minerva Chir. 2007. 62:101–113.
4. Lee EJ, Chung S, Lee RA, Lee SH, Kim KH, Park EB. Local resection for treatment of early colorectal cancer. J Korean Soc Coloproctol. 2004. 20:399–404.
5. Cahill RA. Regional nodal staging for early stage colon cancer in the era of endoscopic resection and N.O.T.E.S. Surg Oncol. 2009. 18:169–175.
6. Bipat S, Glas AS, Slors FJ, Zwinderman AH, Bossuyt PM, Stoker J. Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging--a meta-analysis. Radiology. 2004. 232:773–783.
7. Facey K, Bradbury I, Laking G, Payne E. Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers. Health Technol Assess. 2007. 11:iii-iv, xi-267.
8. Kato H, Miyazaki T, Nakajima M, Takita J, Kimura H, Faried A, et al. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma. Cancer. 2005. 103:148–156.
9. Yamazaki Y, Saitoh M, Notani K, Tei K, Totsuka Y, Takinami S, et al. Assessment of cervical lymph node metastases using FDG-PET in patients with head and neck cancer. Ann Nucl Med. 2008. 22:177–184.
10. Jager GJ, Barentsz JO, Oosterhof GO, Witjes JA, Ruijs SJ. Pelvic adenopathy in prostatic and urinary bladder carcinoma: MR imaging with a three-dimensional TI-weighted magnetization-prepared-rapid gradient-echo sequence. AJR Am J Roentgenol. 1996. 167:1503–1507.
11. Kitajima K, Murakami K, Yamasaki E, Fukasawa I, Inaba N, Kaji Y, et al. Accuracy of 18F-FDG PET/CT in detecting pelvic and paraaortic lymph node metastasis in patients with endometrial cancer. AJR Am J Roentgenol. 2008. 190:1652–1658.
12. Beets-Tan RG, Beets GL. Rectal cancer: review with emphasis on MR imaging. Radiology. 2004. 232:335–346.
13. Vogel WV, Wiering B, Corstens FH, Ruers TJ, Oyen WJ. Colorectal cancer: the role of PET/CT in recurrence. Cancer Imaging. 2005. 5(Spec No A):S143–S149.
14. Sun L, Wu H, Guan YS. Colonography by CT, MRI and PET/CT combined with conventional colonoscopy in colorectal cancer screening and staging. World J Gastroenterol. 2008. 14:853–863.
15. Lubezky N, Metser U, Geva R, Nakache R, Shmueli E, Klausner JM, et al. The role and limitations of 18-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) scan and computerized tomography (CT) in restaging patients with hepatic colorectal metastases following neoadjuvant chemotherapy: comparison with operative and pathological findings. J Gastrointest Surg. 2007. 11:472–478.
16. Llamas-Elvira JM, Rodriguez-Fernandez A, Gutierrez-Sainz J, Gomez-Rio M, Bellon-Guardia M, Ramos-Font C, et al. Fluorine-18 fluorodeoxyglucose PET in the preoperative staging of colorectal cancer. Eur J Nucl Med Mol Imaging. 2007. 34:859–867.
17. Kantorova I, Lipska L, Belohlavek O, Visokai V, Trubac M, Schneiderova M. Routine (18)F-FDG PET preoperative staging of colorectal cancer: comparison with conventional staging and its impact on treatment decision making. J Nucl Med. 2003. 44:1784–1788.
18. Falk PM, Gupta NC, Thorson AG, Frick MP, Boman BM, Christensen MA, et al. Positron emission tomography for preoperative staging of colorectal carcinoma. Dis Colon Rectum. 1994. 37:153–156.
19. Buchmann I, Ganten TM, Haberkorn U. [18F]-FDG-PET in the diagnostics of gastrointestinal tumors. Z Gastroenterol. 2008. 46:367–375.
20. Yoo JJ, Lee SH, Ahn BK, Baek SU, Lee SM. Positron emission tomography (PET)-computed tomography (CT) for preoperative staging of colorectal cancers. J Korean Soc Coloproctol. 2008. 24:201–206.
21. Tsunoda Y, Ito M, Fujii H, Kuwano H, Saito N. Preoperative diagnosis of lymph node metastases of colorectal cancer by FDG-PET/CT. Jpn J Clin Oncol. 2008. 38:347–353.
22. Skibber JM, Minsky BD, Hoff PM. DeVita VT, Hellman S, Rosenberg SA, editors. Cancer of the colon. Cancer, Principles and Practice of Oncology. 2001. 6th ed. Philadelphia: Lippincott, Williams & Wilkins;1216–1271.
23. Shin SS, Jeong YY, Min JJ, Kim HR, Chung TW, Kang HK. Preoperative staging of colorectal cancer: CT vs. integrated FDG PET/CT. Abdom Imaging. 2008. 33:270–277.
24. Strauss LG. Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients. Eur J Nucl Med. 1996. 23:1409–1415.
25. Inoue K, Sato T, Kitamura H, Ito M, Tsunoda Y, Hirayama A, et al. Improvement of the diagnostic accuracy of lymph node metastases of colorectal cancer in 18F-FDG-PET/CT by optimizing the iteration number for the image reconstruction. Ann Nucl Med. 2008. 22:465–473.
XML Download